4801 - 4810 of 7916 Results
Title
Year
- Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs2019OPENTitle: Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 107Issue #: 3Start Page: 553End Page: 562Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.1634Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939141Citation Count: 14
- LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients2019OPENTitle: LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patientsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-13413-wBest OA location URL: https://www.nature.com/articles/s41467-019-13413-w.pdfCitation Count: 145
-
RESTRICTEDTitle: Targeting Alpha-Synuclein as a Therapy for Parkinson’s DiseaseJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2019.00299Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2019.00299/pdfCitation Count: 217
-
OPENTitle: Cerebellar Deep Brain Stimulation for Acquired HemidystoniaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 2Start Page: 188End Page: 193Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12876Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12876Citation Count: 45
- Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's Disease2019RESTRICTEDTitle: Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 3Start Page: 457End Page: 467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27928Citation Count: 50
- Effectiveness of Physiotherapy on Freezing of Gait in Parkinson's Disease: A Systematic Review and Meta‐Analyses2019RESTRICTEDTitle: Effectiveness of Physiotherapy on Freezing of Gait in Parkinson's Disease: A Systematic Review and Meta‐AnalysesJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 4Start Page: 523End Page: 536Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27936Citation Count: 54
- Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration2019OPENTitle: Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegenerationJournal Name: The FASEB JournalPublisher: WileyVol: 34Issue #: 1Start Page: 1679End Page: 1694Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1096/fj.201900567rrBest OA location URL: https://europepmc.org/articles/pmc7212500?pdf=renderCitation Count: 80
-
RESTRICTEDTitle: Suicidal risk and demoralization in Parkinson diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 267Issue #: 4Start Page: 966End Page: 974Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-019-09632-2Citation Count: 25
- Differences in topological progression profile among neurodegenerative diseases from imaging data2019OPENTitle: Differences in topological progression profile among neurodegenerative diseases from imaging dataJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.49298Best OA location URL: https://doi.org/10.7554/elife.49298Citation Count: 12
-
OPENTitle: Risks and benefits of unapproved disease-modifying treatments for neurodegenerative diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000008699Best OA location URL: https://europepmc.org/articles/pmc7011691?pdf=renderCitation Count: 29